Cheplapharm
Prescription Drugs
Overview
Cheplapharm is a family-run German pharmaceutical company that acquires established branded medicines and markets them worldwide. It manages GxP-relevant science IT systems and hires science IT systems managers. The company is headquartered in Greifswald, Germany.
Jobs
In office · Full-Time · 4+ years exp · Greifswald
Master Data Management
Apply
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Data Science
50% ▲
Leadership
50% ▲
People
Carsten Brandt
Verantwortlich für den Inhalt nach § 18 Abs. 2 MStV
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Tech stack
Technologies named in job postings at Cheplapharm over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
43/100
Practices & domains
Master Data Management
Sign in to see how your skills match this stack
Sign In
News
Pharmaceutical Executive Daily: Sanofi & Cheplapharm Form Strategic Partnership PharmExec
GSK is acquiring a trispecific T-cell engager from Chimagen Biosciences and Sanofi expanding its manufacturing partnership with Cheplapharm, Stewart Gandolf discusses why pharma marketing now has to write for both people and AI, and Dr. Elena Christofides
Read more
Report
Latham & Watkins Advises Cheplapharm on €1.2 Billion Term Loan B
Latham & Watkins LLP has advised Cheplapharm Arzneimittel GmbH (Cheplapharm), a European leader in well-established medicines,...
Read more
Report
Report
CHEPLAPHARM to Accelerate Global Supply Chain Digitalization with TraceLink MINT
TraceLink, the world
Read more
Report
Report
Cheplapharm targets blockbuster IPO this year, sources say
German pharma group Cheplapharm is planning to list on the stock exchange in the second half of the year in a deal that could value the company at 10-12 billion euros ($11.8-14.1 billion), including debt, people close to the matter said. Cheplapharm has n
Read more
Report
AstraZeneca sells European rights for schizophrenia drug to Cheplapharm
The treatment, Seroquel, and another version, SeroquelXR, have lost patent protections in Europe and Russia, AstraZeneca said. The drug variants are primarily used to treat schizophrenia and bipolar...
Read more
Report
AstraZeneca sells acid reflux drug rights to Germany's Cheplapharm
Cheplapharm will pay AstraZeneca about $243 million for Losec, a proton pump inhibitor developed by the British drugmaker. The global commercial rights being sold to Cheplapharm, for Losec (omeprazol...
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Greifswald
Germany
HQ
500-1000 est. staff